Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Vaxart Stock Is Crushing It Today

TheMotleyFool

0 0

Shares of Vaxart (NASDAQ: VXRT) were soaring 20.8% as of 11:22 a.m. EDT on Monday. The huge jump came after the biotech announced Food and Drug Administration clearance to begin a phase 1 clinical trial for Vaxart's oral coronavirus vaccine candidate.

Vaxart reported promising pre-clinical results for its oral COVID-19 vaccine candidate in April. But investors really want to see how the investigational vaccine will work in humans. Thanks to the FDA clearance, they're about to get that opportunity.

Image source: Getty Images.

Source Fool.com

Like: 0

VXRT

Share